BOQRE23 - Department of Military Affairs - Indian Army

Frusemide 20mg 2ml Inj,Eplerenone 25mg Tab,Bacillus Clausii 2 billion spores 5ml,Chlordiazepoxide 5

Goods
Qty:24K

Tender Timeline

Tender Issue
June 5, 2025 at 11:37 AM

Tender Title: BOQRE23
Reference Number: 84805b32
Issuing Authority: Department of Military Affairs, Ministry of Defence

Scope of Work and Objectives

The primary aim of this tender is to procure essential pharmaceutical products for the Department of Military Affairs under the Ministry of Defence. The procurement includes a specific list of medications that will be utilized within military healthcare facilities. This competitive bidding process ensures that the required quantities of high-quality medical supplies are available for effective healthcare delivery to military personnel.

Eligibility Criteria

To participate in this tender, bidders must meet several eligibility criteria. Typically, bidders are required to be registered entities with valid licenses for the supply of pharmaceuticals in the country. Additionally, bidders must demonstrate experience in similar supply contracts and have sufficient financial resources to support the execution of the contract. Compliance with current pharmaceutical regulations is also mandatory.

Technical Requirements

The technical requirements for this tender include:

  • Medications must meet the specifications outlined in the tender documents.
  • All pharmaceutical products should comply with recognized quality standards and certifications.
  • Vendors need to provide necessary documentation to validate that the products align with safety and efficacy requirements.

The products of interest include:

  • Frusemide 20mg 2ml injections
  • Eplerenone 25mg tablets
  • Bacillus Clausii 2 billion spores (5ml)
  • Chlordiazepoxide 5mg

Bidders should possess the capability to deliver the exact quantities as indicated in the tender, which collectively totals 23,988 units.

Financial Requirements

Bidders must provide a financial bid detailing the costs associated with the procurement of the aforementioned medications. Financial stability and previous sales experience may be assessed to ensure bidders can fulfill the contract requirements without interruptions.

Document Submission Details

All documents related to the submission must comply with the specified formats and guidelines provided in the tender documentation. Bidders must ensure timely submission of their bids, including necessary credentials, financial proposals, and product specifications.

Special Provisions

This tender may contain specific provisions aimed at encouraging Micro, Small, and Medium Enterprises (MSE) and startups to participate in this procurement process. Benefits may include qualification relaxations, financial incentives, or reserved quotas, aligning with the government policies to promote local businesses.

Evaluation Process

The evaluation of bids will be based on the technical and financial submissions provided by the bidders. The evaluation team will shortlist bidders based on their adherence to technical specifications, and preferences may be given to local content and procurement initiatives in alignment with governmental directives.

Delivery Locations

The successful bidders will be required to deliver the pharmaceutical products to predetermined military healthcare locations across the country as per the directives from the Department of Military Affairs.

Contact Information

While specific contact information for inquiries has not been disclosed, bidders are encouraged to follow the submission guidelines laid down in the tender documents for clarification or further inquiries related to the tender process.


Tender BOQ Items

15 Items
1.

Frusemide 20mg 2ml Inj

Frusemide 20mg, 2ml Inj

Qty:30
Unit:amp
15
2.

Eplerenone 25mg Tab

Qty:138
Unit:no
15
3.

Bacillus Clausii 2 billion spores 5ml

Bacillus Clausii 2 billion spores/5ml

Qty:1260
Unit:bott
15
4.

Chlordiazepoxide 5mg plus Clidinium 2.5mg plus Dicyclomine 10mg Tab

Chlordiazepoxide (5mg) + Clidinium 2.5mg + Dicyclomine 10mg Tab

Qty:600
Unit:no
15
5.

Mesalamine Suppository 500mg

Qty:600
Unit:no
15
6.

Antispasmodic Tab containing Mefenamic acid 250mg Dicyclomine HCl 10mg

Antispasmodic Tab containing Mefenamic acid 250mg & Dicyclomine HCl 10mg

Qty:4200
Unit:no
15
7.

Tab Levosulpiride 25mg

Qty:396
Unit:no
15
8.

Tab Entacavir 0.5mg

Qty:264
Unit:no
15
9.

Antacid chewable containing 300 Silicate 25 Simethicone 25

Qty:3960
Unit:no
15
10.

Oint Diltiazem 2 percent tube of 30mg

Oint Diltiazem 2% tube of 30mg

Qty:120
Unit:tube
15
11.

Trypsin with chymotrypsin Tab

Qty:6000
Unit:no
15
12.

Ranitidine 150mg Tab

Qty:3300
Unit:no
15
13.

Ranitidine HCl 50mg 2ml Inj

Ranitidine HCl 50mg, 2ml Inj

Qty:60
Unit:amp
15
14.

Metoclopramide HCl 5mg ml 2ml Inj

Metoclopramide HCl 5mg/ml, 2ml Inj

Qty:60
Unit:amp
15
15.

Isabgol Husk

Qty:3000
Unit:sachet
15

General Information

Item Category
Frusemide 20mg 2ml Inj , Eplerenone 25mg Tab , Bacillus Clausii 2 billion spores 5ml , Chlordiazepoxide 5mg plus Clidinium 2.5mg plus Dicyclomine 10mg Tab , Mesalamine Suppository 500mg , Antispasmodic Tab containing Mefenamic acid 250mg Dicyclomine HCl 10mg , Tab Levosulpiride 25mg , Tab Entacavir 0.5mg , Antacid chewable containing 300 Silicate 25 Simethicone 25 , Oint Diltiazem 2 percent tube of 30mg , Trypsin with chymotrypsin Tab , Ranitidine 150mg Tab , Ranitidine HCl 50mg 2ml Inj , Metoclopramide HCl 5mg ml 2ml Inj , Isabgol Husk
Ministry Name
Organisation Name

Financial Information

Bid Offer Validity
180 (Days)
Past Performance
10 %
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Item wise evaluation/
Inspection Required
Yes
Technical Clarifications Time
2 Days

Tender Documents

5 Documents
GeM-Bidding-7930793.pdfMain Document
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
Buyer uploaded ATC documentATC ATC
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Documents Required from Seller

  • Experience Criteria
  • Past Performance
  • Bidder Turnover
  • Certificate (Requested in ATC)
  • OEM Authorization Certificate
  • OEM Annual Turnover
  • Additional Doc 1 (Requested in ATC)
  • Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
  • the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Similar Tenders

View All

Lignocaine HCl 2 percent without Adrenalin 30 ml Inj suitable for ophthalmic use also,Lignocaine HC

GEM
Goods
Qty:45.8K
4 Files
Indian Army
Boq › Boql
Lignocaine HCl 2 percent without Adrenalin 30 ml Inj suitable for ophthalmic use also , Lignocaine HCl 2 percent with Adrenaline 1.80000 30 ml Inj , Atropine Sulphate 0.6 mg, 1 ml Inj , Paracetamol with Cysteine HCl monohydrate infusion 1000 mg or 100 ml , Pregabalin 75 mg plus Methylcobalamine 1500 mcg Tab , Pheniramine Maleate Inj 22.75 mg ml amp of 2 ml , Noradrenaline Bitartrate 2 mg ml, 2 ml Inj , Lorazepam 2 mg or ml, 2 ml Inj , Inj Fosphenytoin 75 mg or ml, 2ml ampoule , Albendazole Syp, each 5 ml containing 200 mg, bott of 10 ml , Tab Artesunate 25 mg plus Sulphadoxine 250 mg and Pyrimethamine 12.5 mg , Chloroquine Phosphate 250 mg Tab , Primaquine 7.5mg base Tab , Tranexamic Acid 500 mg or 5ml Inj , Isosorbide Dinitrate 10 mg Tab , Adenosine 3 mg or ml, 2 ml Inj , Propranolol TR 40 mg, Tab , Ramipiril 2.5 mg Tab , Labetalol HCl 5mg or ml, 4ml Inj , Chlorhexidine mouth wash with 0.12 percent sugar, alcohol free, bottle of 450 to 500 ml in amber coloured bottle , Mupirocin 2 percent Oint, tube of 5 gm , Sodium Hypochlorite 5 percentage , Hydrogen peroxide solution with stabilizer IP 20 volume 500 ml bott , Povidone Iodine solution 5 percent bottle of 100 ml , Antispasmodic Tab containing Mefenamic Acid 250 mg and Dicyclomine HCl 10 mg , Antacid Gel each 5ml containing dried Aluminium Hydroxide gel IP 250mg, Magnesium hydroxide NF 250mg and Methyl Polysiloxane 50mg Bottle of 170 ml , Anti haemorrhoidal ointment containing Hydrocortisone acetate 5.58mg, Framycetin 10mg, Heparin 100IU, Esculoside 10mg, Ethylaminobenzoate 10mg, Butylaminobenzoate 10mg per gm tube of 10 gm , Dicyclomine HCl 20mg Inj , Hyoscine Bromide Inj 20 mg or ml ,1ml Inj , Oral Rehydration powder, sachet of 20.5 g, each containing Sodium Chloride IP 2.6 g, Anhydrous Dextrose IP 13.5 g, Potassium Chloride IP 1.5 g and Sodium Citrate IP 2.9 gm to make the mixture , Loperamide 2mg Tab , Tab Thyroxine 50 mcg , Xylometazoline HCl 0.05 percent wv nasal solution for paed use, bott of 10ml , Cetirizine Syp 5mg or 5ml bott of 60 ml , Cyproheptadine HCl 2 mg or 5 ml bott of 100 ml , Ondansetron Syp 2 mg or 5ml in bott of 30 ml , Iron drops Paediatric. Each ml contains Ferrous Fumarate containing 10 12.5 mg elemental Iron, Folic Acid 0.1 0.5 mg and Vit B12 3 10 mcg, bottle of 15 ml , Ipratropium Bromide Respirator soln 500 mcg 2 ml respule , Levo Salbutamol aerosol pack of 200 metered doses each metered dose supplies 50 mcg of Levo Salbutamol , Levo Salbutamol Sulphate, 2.5 ml, containing 1.25 mg, Respule , Dextrose Inj 25 percent, 25 ml Inj , Multi Vit Inj IV 2 10 ml with minimum constituents having Thiamine B1 30mg or ml, Pyridoxine B6 30mg or ml and B12 Cyanocobalamin 300 mcg or ml , Tab Etoricoxib 90 mg , Amoxycillin oral susp containing Amoxycillin base 125 mg per 5 ml after reconstitution bottle of 30 ml , Artemether 80 mg, Lumefantrine 480 mg Tablet , Tetanus Toxoid, purified, absorbed rubber capped, Vial of 5 ml 10 Doses , Tab Aceclofenac Sodium 100mg plus Paracetamol 500mg , Syp Chlopheniramine Maleate Maleate 1mg plus Phenylephrine 2.5 mg bott of 100ml , Oint Povidine Iodine tube of 30gm , Mouth ulcer gel tube of 10 gm Choline Salicylate , Diclofenac Spray bott of 60ml , Betadine Gargle bott of 100ml
June 5, 2025
June 30, 2025 at 9:00 AM
View Details

Frequently Asked Questions

The eligibility requirements include being a registered entity, having the necessary licenses for supplying pharmaceutical products, and possessing prior experience in similar procurement contracts. Bidders must also demonstrate financial capability and compliance with pharmaceutical regulations.

Bidders must provide relevant certification for the pharmaceutical products being offered. This includes certifications to prove the quality and efficacy of the medications, compliance with safety standards, and other relevant documentation as outlined in the tender documents.

To submit a bid, interested parties must first register on the relevant procurement platform. Following registration, bidders need to complete and submit their proposals adhering to the outlined specifications, ensuring all required documents are prepared as per guidelines specified in the tender.

Documents for bid submissions must adhere to the specified formats stated in the tender guidelines. Typically, electronic submissions should be provided in PDF or other specified formats, ensuring compliance with all technical submission criteria outlined in the tender documentation.

An Earnest Money Deposit (EMD) is generally required to confirm the seriousness of bids. The amount and specific conditions for the EMD will be detailed in the tender documents. The EMD will be forfeited in cases of non-compliance or non-fulfillment of contract terms as stipulated in the tender agreement.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders